Endometrial ablation in women with abnormal uterine bleeding aged fifty and over.
Endometrial ablation, rapidly becoming a standard operation for the management of abnormal uterine bleeding, is usually performed for patients between ages 35 and 45. This study reports on the results of resectoscopic endometrial ablation for 26 patients aged 50 and older, followed from 7 to 43 months (average follow-up period, 21 months). Seventeen of the patients were menopausal at the time of the procedure or became menopausal during the follow-up period, with 13 on combined estrogen and progestin therapy and 4 on unopposed estrogen (because of progestin intolerance). Twenty-three of the 26 patients (88%) are amenorrheic, one premenopausal patient has normal periods and none have failed. The fear of hiding glandular tissue that subsequently becomes malignant is discussed and believed to be highly unlikely to occur.
Brooks
P G
PG
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
Serden
S P
SP
D000367:Age Factors; D000368:Aged; D004564:Electrocoagulation / Q000295:instrumentation; D004717:Endometrium / Q000601:surgery*; D015914:Estrogen Replacement Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D020702:Hysteroscopes; D008875:Middle Aged; D016896:Treatment Outcome; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D014599:Uterus / Q000473:pathology